Dr. Gustavo S. Oderich, MD
Vascular Surgery (Vascular Surgery Physician)
- Medicare participating
At a glance
- Years since graduation
- 31
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 132
Licensed in Texas since 2020, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular Surgery Physician primary
TX license S8221 (first issued 2020; active) · AZ license 41799 · FL license ME143785 · MN license 43750 -
Surgery Physician
TX license S8221 (first issued 2020; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baylor St Lukes Medical Center Houston, TX
Medical groups
- Baylor College of Medicine (1,240 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 132
- Services billed
- 264
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 36 | 33 |
| Exposure of groin artery for delivery of graft | 19 | 19 |
| New patient office or other outpatient visit, 45-59 minutes | 17 | 17 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | 17 |
| Established patient office or other outpatient visit, 10-19 minutes | 12 | 11 |
| Telephone medical discussion with physician, 5-10 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 16 companies reported 66 payments worth $47,952 in total to this clinician.
| W. L. Gore & Associates, Inc. | $36,590 |
|---|---|
| Cook Incorporated | $9,208 |
| GE Healthcare | $464 |
| Cook Medical LLC | $192 |
| Medtronic, Inc. | $191 |
| Bolton Medical Inc | $168 |
| Angiodynamics, Inc. | $166 |
| Penumbra, Inc. | $149 |
| Consulting Fee | $31,155 |
|---|---|
| Travel and Lodging | $11,765 |
| Food and Beverage | $5,033 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| W. L. Gore & Associates, Inc. Apr 8, 2025 | Consulting Fee Product in Development · Devices | $14,535 |
| Cook Incorporated Jul 22, 2025 | Travel and Lodging ZENITH ALPHA · Aortic Intervention · travel to Rio De Janeiro, BRA, Brazil | $9,208 |
| W. L. Gore & Associates, Inc. Oct 24, 2025 | Consulting Fee Product in Development · Devices | $5,440 |
| W. L. Gore & Associates, Inc. Nov 21, 2025 | Consulting Fee GORE VIABAHN VBX Balloon Expandable Endo · Devices | $4,080 |
| W. L. Gore & Associates, Inc. Nov 21, 2025 | Consulting Fee GORE VIABAHN VBX Balloon Expandable Endo · Devices | $2,380 |
| W. L. Gore & Associates, Inc. Apr 8, 2025 | Consulting Fee Product in Development · Devices | $1,710 |
| W. L. Gore & Associates, Inc. Feb 28, 2025 | Travel and Lodging GORE VIABAHN VBX Balloon Expandable Endo · Devices · travel to Phoenix, AZ · in-kind | $1,160 |
| W. L. Gore & Associates, Inc. Feb 28, 2025 | Consulting Fee GORE EXCLUDER Iliac Branch Endoprosthesis · Devices | $855 |
| W. L. Gore & Associates, Inc. Oct 24, 2025 | Consulting Fee Product in Development · Devices | $680 |
| W. L. Gore & Associates, Inc. Nov 21, 2025 | Consulting Fee GORE VIABAHN VBX Balloon Expandable Endo · Devices | $680 |
All 21 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| W. L. Gore & Associates, Inc. Dec 12, 2025 | Consulting Fee Product in Development · Devices | $510 |
| W. L. Gore & Associates, Inc. Nov 21, 2025 | Consulting Fee GORE VIABAHN VBX Balloon Expandable Endo · Devices | $4,080 |
| W. L. Gore & Associates, Inc. Nov 21, 2025 | Consulting Fee GORE VIABAHN VBX Balloon Expandable Endo · Devices | $2,380 |
| W. L. Gore & Associates, Inc. Nov 21, 2025 | Consulting Fee GORE VIABAHN VBX Balloon Expandable Endo · Devices | $680 |
| W. L. Gore & Associates, Inc. Oct 24, 2025 | Consulting Fee Product in Development · Devices | $5,440 |
| W. L. Gore & Associates, Inc. Oct 24, 2025 | Consulting Fee Product in Development · Devices | $680 |
| Cook Incorporated Jul 22, 2025 | Travel and Lodging ZENITH ALPHA · Aortic Intervention · travel to Rio De Janeiro, BRA, Brazil | $9,208 |
| W. L. Gore & Associates, Inc. Jun 6, 2025 | Travel and Lodging GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis · Devices · travel to New Orleans, LA · in-kind | $206 |
| W. L. Gore & Associates, Inc. Apr 8, 2025 | Consulting Fee Product in Development · Devices | $14,535 |
| W. L. Gore & Associates, Inc. Apr 8, 2025 | Consulting Fee Product in Development · Devices | $1,710 |
| W. L. Gore & Associates, Inc. Feb 28, 2025 | Travel and Lodging GORE VIABAHN VBX Balloon Expandable Endo · Devices · travel to Phoenix, AZ · in-kind | $1,160 |
| W. L. Gore & Associates, Inc. Feb 28, 2025 | Consulting Fee GORE EXCLUDER Iliac Branch Endoprosthesis · Devices | $855 |
| W. L. Gore & Associates, Inc. Feb 28, 2025 | Consulting Fee Product in Development · Devices | $285 |
| W. L. Gore & Associates, Inc. Feb 27, 2025 | Travel and Lodging GORE TAG Thoracic Branch Endoprosthesis · Devices · travel to Phoenix, AZ · in-kind | $317 |
| W. L. Gore & Associates, Inc. Feb 27, 2025 | Travel and Lodging GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis · Devices · travel to Phoenix, AZ · in-kind | $63.65 |
| W. L. Gore & Associates, Inc. Feb 26, 2025 | Travel and Lodging GORE TAG Thoracic Branch Endoprosthesis · Devices · travel to Phoenix, AZ · in-kind | $69.98 |
| W. L. Gore & Associates, Inc. Feb 25, 2025 | Travel and Lodging GORE TAG Thoracic Branch Endoprosthesis · Devices · travel to Phoenix, AZ · in-kind | $259 |
| W. L. Gore & Associates, Inc. Feb 25, 2025 | Travel and Lodging GORE TAG Thoracic Branch Endoprosthesis · Devices · travel to Phoenix, AZ · in-kind | $49.59 |
| W. L. Gore & Associates, Inc. Feb 17, 2025 | Travel and Lodging GORE TAG Thoracic Branch Endoprosthesis · Devices · travel to Phoenix, AZ · in-kind | $73.50 |
| W. L. Gore & Associates, Inc. Feb 4, 2025 | Travel and Lodging GORE TAG Thoracic Branch Endoprosthesis · Devices · travel to Phoenix, AZ · in-kind | $227 |
| W. L. Gore & Associates, Inc. Feb 4, 2025 | Travel and Lodging GORE TAG Thoracic Branch Endoprosthesis · Devices · travel to Phoenix, AZ · in-kind | $131 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $110,708 in research payments for these studies, mostly to the institutions running them.
- Advanced F-B-EVAR in Allia HOR - Clinical outcomes and quality of life measures
GE Healthcare
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.